New anesthesia drug may reduce Post-Surgery confusion in seniors

NCT ID NCT05514405

Recruiting now Symptom relief Sponsor: Inje University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether remimazolam, a newer anesthesia drug, causes less confusion (delirium) after surgery than the standard drug propofol in elderly patients having hip or knee replacement. Researchers will monitor 82 participants for three days after surgery to check for delirium and overall recovery quality. The goal is to find a safer anesthesia option for older adults.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Remimazolam (Byfavo) and Propofol
What this could lead to: If remimazolam works better, it could offer a safer anesthesia option for elderly patients, reducing confusion after surgery.
What could go wrong: This is a small, early-stage trial with only 82 participants. The results may not apply to all patients, and the difference between drugs might be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMUR FRACTURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Femoral Fractures femoral neck fracture hip fracture osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEMUR FRACTURE HIP FRACTURES KNEE OSTEOARTHRITIS

Contacts and locations

Locations

Sanggye Paik hospital
RECRUITING

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.